🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel(s) Serving Size
Fat/Fatty Acid Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 250mg UL 3000mg

Other Ingredients

Gelatin Water Glycerin Polysorbate 80

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Pregnant Women Adult Female (18 - 50 Years) Lactating

Product Information

📋 Directions for Use

DOSAGE AND ADMINISTRATION: Before, during and after pregnancy, one caplet and one softgel taken by mouth daily, or as directed by a physician. The caplet and softgel may be taken together or at different times of the day.

⚠️ Warnings & Precautions

Caution should be exercised to ensure that the prescribed dose of DHA does not exceed 1 gram (1,000 mg) per day.

Contains Soy.

🧪 Formulation Notes

250 mg DHA Softgel

Contains Stool Softener

INDICATIONS: PNNV OB+DHA is a prescription regimen of prenatal multivitamin, multi-mineral and Omega-3 fatty acid supplements indicated for use in improving the nutritional status of women throughout pregnancy and in the post-natal period for both lactating and non-lactating mothers.

30 Softgels: Docosahexaenoic Acid (DHA) 250 mg

Each PNV OB+DHA softgel contains: 250 mg Docosahexaenoic Acid (DHA)

May contain Vanillin.

Also contains Eicosapentaenoic Acid (EPA) and other Omega-3 Fatty Acids.

Contains Soy.

Additional Information

30-Day Supply

PNV OB+DHA is also useful in improving the nutritional status prior to conception.

Consult package insert for full prescribing information.

Rx Only

DHA is contained in the oil derived from fish (tuna).

Cloudiness of the softgel is a characteristic of natural fish oil.

PharmaPureRx

List No. 11560 ENY Rev. 00-33265

Product Details

UPC / SKU 7 31477 47177 1
DSLD Entry Date 2014-10-10
Product Type Fat/Fatty Acid
Form Softgel Capsule
Bundle PNV OB+DHA
DSLD ID 37180
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →